Loading…
2nd Pharmacovigilance Oversight has ended
Back To Schedule
Tuesday, March 28 • 11:45am - 12:30pm
BENEFIT-RISK ASSESSEMENT FOR DRUG AND BIOLOGICAL PRODUCTS

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
What, Why and How is BRA done across the Product Life Cycle
  • Analyze FDA's B-R framework
  • How can limitations/uncertainties be tackled/addressed
  • Discuss different initiatives and the future
Speakers
avatar for Siva Kumar

Siva Kumar

Global Phv Surveillance Physician Sr Manager, TEVA

Tuesday March 28, 2023 11:45am - 12:30pm EDT
Le Méridien Philadelphia
  General Session